X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41) 41
male (27) 27
female (26) 26
index medicus (26) 26
infectious diseases (26) 26
adult (24) 24
hiv (22) 22
hiv infections - drug therapy (22) 22
middle aged (16) 16
anti-hiv agents - therapeutic use (15) 15
antiretroviral therapy (14) 14
hiv infection (13) 13
clinical trials (12) 12
human immunodeficiency virus--hiv (12) 12
aids (11) 11
antiretroviral drugs (11) 11
hiv infections - complications (11) 11
immunology (11) 11
treatment outcome (11) 11
aged (9) 9
antiviral agents (9) 9
pharmacology & pharmacy (9) 9
risk factors (9) 9
drug therapy, combination (8) 8
highly active antiretroviral therapy (8) 8
human immunodeficiency virus (8) 8
rna (8) 8
therapy (8) 8
acquired immune deficiency syndrome--aids (7) 7
aids/hiv (7) 7
anti-hiv agents - administration & dosage (7) 7
antiretroviral agents (7) 7
cd4 lymphocyte count (7) 7
pharmacogenetics (7) 7
viral load (7) 7
adults (6) 6
anti-hiv agents - adverse effects (6) 6
drug therapy (6) 6
infection (6) 6
medicine, general & internal (6) 6
mortality (6) 6
reverse transcriptase inhibitors - administration & dosage (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
analysis (5) 5
antiretroviral therapy, highly active (5) 5
article (5) 5
hiv infections - immunology (5) 5
longitudinal studies (5) 5
medicine (5) 5
myocardial-infarction (5) 5
polymorphism, single nucleotide (5) 5
protease inhibitors (5) 5
virology (5) 5
absorptiometry, photon (4) 4
acquired immune deficiency syndrome (4) 4
antiretrovirals (4) 4
biomarkers (4) 4
c-reactive protein (4) 4
cardiovascular disease (4) 4
care and treatment (4) 4
coagulation (4) 4
cohort studies (4) 4
epidemiology (4) 4
health aspects (4) 4
hiv patients (4) 4
human-immunodeficiency-virus (4) 4
infected patients (4) 4
interleukin-2 - therapeutic use (4) 4
lopinavir (4) 4
outcomes (4) 4
patients (4) 4
pharmacogenomics (4) 4
polymorphism, genetic (4) 4
polymorphisms (4) 4
research (4) 4
reverse transcriptase inhibitors - adverse effects (4) 4
reverse transcriptase inhibitors - therapeutic use (4) 4
ribonucleic acid--rna (4) 4
risk (4) 4
ritonavir (4) 4
science (4) 4
studies (4) 4
tenofovir (4) 4
young adult (4) 4
610 medicine & health (3) 3
anti-retroviral agents (3) 3
anti-retroviral agents - therapeutic use (3) 3
antiretroviral therapy, highly active - methods (3) 3
benzoxazines - administration & dosage (3) 3
cardiovascular diseases (3) 3
cd4 antigen (3) 3
cholesterol (3) 3
clinic for infectious diseases (3) 3
clinical outcomes (3) 3
comparative analysis (3) 3
coronary artery disease (3) 3
coronary-heart-disease (3) 3
diabetes-mellitus (3) 3
dosage and administration (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 08/2019, Volume 81, Issue 4, pp. 456 - 462
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2010, Volume 51, Issue 7, pp. 855 - 864
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2011, Volume 56, Issue 1, p. 36
Among a subgroup of participants in the Strategies for Management of Antiretroviral Therapy (SMART) Trial that were naive to antiretroviral therapy (ART) or... 
Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Cytokines | Human immunodeficiency virus--HIV | Mortality | Coagulation | Biomarkers | Drug therapy | Patients
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 08/2018, Volume 73, pp. 1 - 2
Journal Article
by Margalida Rotger and Tracy R. Glass and Thomas Junier and Jens Lundgren and James D. Neaton and Estella S. Poloni and Angélique B. van 't Wout and Rubin Lubomirov and Sara Colombo and Raquel Martinez and Andri Rauch and Huldrych F. Günthard and Jacqueline Neuhaus and Deborah Wentworth and Danielle van Manen and Luuk A. Gras and Hanneke Schuitemaker and Laura Albini and Carlo Torti and Lisa P. Jacobson and Xiuhong Li and Lawrence A. Kingsley and Federica Carli and Giovanni Guaraldi and Emily S. Ford and Irini Sereti and Colleen Hadigan and Esteban Martinez and Mireia Arnedo and Lander Egaña-Gorroño and Jose M. Gatell and Matthew Law and Courtney Bendall and Kathy Petoumenos and Jürgen Rockstroh and Jan-Christian Wasmuth and Kabeya Kabamba and Marc Delforge and Stephane De Wit and Florian Berger and Stefan Mauss and Mariana de Paz Sierra and Marcelo Losso and Waldo H. Belloso and Maria Leyes and Antoni Campins and Annalisa Mondi and Andrea De Luca and Ignacio Bernardino and Mónica Barriuso-Iglesias and Ana Torrecilla-Rodriguez and Juan Gonzalez-Garcia and José R. Arribas and Iuri Fanti and Silvia Gel and Jordi Puig and Eugenia Negredo and Mar Gutierrez and Pere Domingo and Julia Fischer and Gerd Fätkenheuer and Carlos Alonso-Villaverde and Alan Macken and James Woo and Tara McGinty and Patrick Mallon and Alexandra Mangili and Sally Skinner and Christine A. Wanke and Peter Reiss and Rainer Weber and Heiner C. Bucher and Jacques Fellay and Amalio Telenti and Philip E. Tarr and MAGNIFICENT Consortium and INSIGHT and Swiss HIV Cohort Study and for the MAGNIFICENT Consortium and the Swiss HIV Cohort Study
Clinical Infectious Diseases, ISSN 1058-4838, 7/2013, Volume 57, Issue 1, pp. 112 - 121
Journal Article
Clinical Trials, ISSN 1740-7745, 10/2019, p. 174077451988161
Background: Evidence from prospectively designed studies to guide on-site monitoring practices for randomized trials is limited. A cluster randomized study,... 
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 10, p. e77138
To compare changes over 48 weeks in body fat, lipids, Metabolic Syndrome and cardiovascular disease risk between patients randomised 1:1 to lopinavir/ritonavir... 
Metabolic Syndrome - etiology | Cardiovascular Diseases - drug therapy | Cholesterol - blood | Humans | Middle Aged | Male | Metabolic Syndrome - metabolism | Cardiovascular Diseases - pathology | Metabolic Syndrome - drug therapy | RNA, Viral - antagonists & inhibitors | HIV-1 - physiology | HIV Infections - pathology | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Body Fat Distribution | Lipodystrophy - drug therapy | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Raltegravir Potassium | Body Mass Index | Cardiovascular Diseases - etiology | Virus Replication - drug effects | Cardiovascular Diseases - metabolism | HIV-1 - drug effects | RNA, Viral - biosynthesis | Risk Factors | Pyrrolidinones - therapeutic use | Logistic Models | Lipodystrophy - metabolism | Lipodystrophy - complications | HIV Infections - complications | Lipodystrophy - pathology | HIV Infections - drug therapy | Lopinavir - therapeutic use | Metabolic Syndrome - pathology | Viral Load - drug effects | HIV Infections - metabolism | Therapy | RNA-directed DNA polymerase | Body fat | Ritonavir | Medical services | Risk | Lipids | Incidence | Body mass index | Randomization | Acquired immune deficiency syndrome--AIDS | Mathematical analysis | Antiretroviral agents | Human immunodeficiency virus--HIV | Lipid metabolism | Lipoproteins (high density) | Antiretroviral drugs | Dual energy X-ray absorptiometry | Statistical analysis | Lopinavir | Health risks | Regression analysis | Ribonucleic acid--RNA | Insulin | Patients | Antiretroviral therapy | Cholesterol | Inhibitors | Protease inhibitors | Body mass | Body size | Nucleosides | Lipodystrophy | Cardiovascular diseases | Metabolic disorders | Smoking | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Medicina (Buenos Aires), ISSN 0025-7680, 06/2010, Volume 70, Issue 3, pp. 265 - 274
La variabilidad interindividual de la respuesta a fármacos reconoce a los aspectos genéticos como su principal explicación. El estudio de polimorfismos... 
Drug selection | Farmacogenómica | Pharmacogenetics | Medicina personalizada | Selección de drogas | Polymorphisms | Personalized medicine | Polimorfismos | Farmacogenética | Pharmacogenomics
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 10/2014, Volume 67, Issue 2, p. 161
  To compare bone mineral density (BMD) changes over 96 weeks in adults virologically failing standard first-line therapy, randomized to raltegravir plus... 
Bone density | Adults | Drug therapy | Clinical outcomes | Virology
Journal Article
Medicina (Buenos Aires), ISSN 1669-9106, 06/2010, Volume 70, Issue 3, pp. 265 - 274
La variabilidad interindividual de la respuesta a fármacos reconoce a los aspectos genéticos como su principal explicación. El estudio de polimorfismos... 
Farmacogenómica | Medicina personalizada | Selección de drogas | Polimorfismos | Farmacogenética
Journal Article
Current Drug Safety, ISSN 1574-8863, 11/2016, Volume 11, Issue 3, pp. 206 - 214
In recent years, several cases of torsade de pointes have been associated with many opioids. However, to present no cases have been reported with tramadol.... 
Journal Article
International Journal of Nephrology, ISSN 2090-214X, 2014, Volume 2014, pp. 381985 - 8
Journal Article
Journal Article
Current Drug Safety, ISSN 1574-8863, 03/2016, Volume 11, Issue 1, pp. 86 - 98
Objective: The actual prevalence of drug induced QTc prolongation in clinical practice is unknown. Our objective was to determine the occurrence and... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2010, Volume 51, Issue 7, p. 855
  Antiretroviral therapy is complicated by drug interactions and contraindications. Novel regimens are needed. This open label study randomly assigned... 
Studies | Antiretroviral drugs | Human immunodeficiency virus--HIV | Drug therapy | Patients | Virology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.